We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,122 hedge funds and large institutions have $193B invested in Johnson & Johnson in 2014 Q4 according to their latest regulatory filings, with 206 funds opening new positions, 784 increasing their positions, 909 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

304% more first-time investments, than exits

New positions opened: 206 | Existing positions closed: 51

7% more funds holding

Funds holding: 1,9892,122 (+133)

0.09% less ownership

Funds ownership: 66.1%66.01% (-0.09%)

3% less capital invested

Capital invested by funds: $199B → $193B (-$5.56B)

8% less funds holding in top 10

Funds holding in top 10: 720659 (-61)

14% less repeat investments, than reductions

Existing positions increased: 784 | Existing positions reduced: 909

34% less call options, than puts

Call options by funds: $1.66B | Put options by funds: $2.52B

Holders
2,122
Holders Change
+133
Holders Change %
+6.69%
% of All Funds
56.36%
Holding in Top 10
659
Holding in Top 10 Change
-61
Holding in Top 10 Change %
-8.47%
% of All Funds
17.5%
New
206
Increased
784
Reduced
909
Closed
51
Calls
$1.66B
Puts
$2.52B
Net Calls
-$858M
Net Calls Change
-$373M

JNJ Hedge Fund Activity: Q4 2014 in Review

2,122 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2014, worth a combined $193B — down 2.8% from $199B a quarter earlier.

Buyers outnumbered sellers: 206 funds opened new JNJ positions and 51 closed out — a net gain of 155 holders — while 784 added to existing stakes and 909 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $920M. The largest seller was T. Rowe Price Associates, cutting an estimated $652M.

  • 2,122 institutional investors held Johnson & Johnson (JNJ) as of Q4 2014, up from 1,989 in Q3 2014.
  • Funds reported $193B of Johnson & Johnson stock for Q4 2014, down 2.8% quarter-over-quarter.
  • 206 funds opened new Johnson & Johnson positions in Q4 2014 and 51 closed out, a net change of +155 holders.
  • The largest Johnson & Johnson buyer in Q4 2014 was Fidelity Investments, an estimated $920M added.
  • The largest Johnson & Johnson seller in Q4 2014 was T. Rowe Price Associates, an estimated $652M sold.

Based on aggregated 13F filings for Q4 2014.